M.P.H Sociomedical Sciences
Friends World College email@example.com
Dr. Sohler is an epidemiologist and health services researcher focused on research to improve access to high quality health care for underserved populations both in the US and internationally. She brings more than 15 years of experience conducting research on approaches to address health and healthcare for people with and at risk for HIV, substance abuse, severe mental disorders, and non communicable disease like diabetes, obesity and cancer. Dr. Sohler’s research areas include both programmatic and intervention evaluation research, as well as population and community based epidemiology inquiries.
In addition to her current appointment with the School of Medicine at CUNY, Dr. Sohler currently also serves as the Director of Research Education at the Haiti Medical Education Project in Port au Prince, Haiti. Prior to joining the faculty at CUNY, Dr. Sohler served as an Assistant Professor of Epidemiology at Columbia University and subsequently at Montefiore Medical Center, Bronx, NY.
Dr. Sohler’s implementation science experience focuses on the examination of barriers to healthcare for underserved populations, evaluation of medical outreach for unstably housed people with HIV, and the examination of how pharmaceutical marketing practices impact health care choices and disparities in treatment for chronic disease.
Bachhuber MA, Arnsten JH, Cunningham CO, Sohler N. Does Medical Cannabis Use Increase or Decrease the Use of Opioid Analgesics and Other Prescription Drugs?. J Addict Med. 2018 Apr 17. doi: 10.1097/ADM.0000000000000404. [Epub ahead of print]
Sohler NL, Starrels JL, Khalid L, Bachhuber MA, Arnsten JH, Nahvi S, Jost J, Cunningham CO. Cannabis Use is Associated with Lower Odds of Prescription Opioid Analgesic Use Among HIV-Infected Individuals with Chronic Pain. Subst Use Misuse. 2018 Aug 24;53(10):1602-1607. doi: 10.1080/10826084.2017.1416408. Epub 2018 Jan 17.
Fox AD, Sohler NL, Frost T, Lopez C, Cunningham CO. Development and evaluation of a community-based buprenorphine treatment intervention. Harm Reduct J. 2017 May 12;14(1):23. doi: 10.1186/s12954-017-0149-y.
Sohler N, Adams BG, Barnes DM, Cohen GH, Prins SJ, Schwartz S. Weighing the evidence for harm from long-term treatment with antipsychotic medications: A systematic review. Am J Orthopsychiatry. 2016;86(5):477-85.
Sohler N, Matti-Orozco B, Young E, Li X, Gregg EW, Ali MK, Bullard KM, Albu JB. Opportunistic Screening for Diabetes and Prediabetes using Hemoglobin A1C in an Urban Primary Care Setting. Endocr Pract. 2016 Feb;22(2):143